March 6 (Bloomberg) -- Frances Hudson, global thematic strategist at Standard Life Investments, talks with Bloomberg's Guy Johnson about global markets and her investment in corporate bonds and currencies. She speaks on Bloomberg Television's "The Pulse."
07:04 - Johnson & Johnson beat analysts’ estimates for third-quarter profit as a lower tax rate helped the world’s biggest maker of health-care products overcome slightly weaker-than-projected sales for key drugs such as Remicade. Gabelli & Co.'s Jeff Jonas and Bloomberg's Cynthia Koons weigh in on "Bloomberg Markets." Jonas owns no stock in J&J. (Source: Bloomberg)
Have We Hit the Bottom in Commodity Prices?
Why Market Correction Didn't Change the M&A Pipeline
Norway's Oil: What'd You Miss?: (Full Show 10/12)
Please upgrade your Browser
Your browser is out-of-date. Please download one of these excellent browsers: